Samuel Louie; Amir A Zeki; Michael Schivo; Andrew L Chan; Ken Y Yoneda; Mark Avdalovic; Brian M Morrissey; Timothy E Albertson The Spanish COPD guidelines propose four COPD phenotypes that ...

Women with COPD, asthma, and OSA may go undiagnosed or without proper care because their symptomatology differs from the classic male presentation.

Introduction Identifying acute hypercapnic respiratory failure is crucial in the initial management of acute exacerbations of COPD. Guidelines recommend obtaining arterial blood samples but these are ...

The US Food and Drug Administration (FDA) has approved mepolizumab as a maintenance treatment for chronic obstructive ...

Long-term oxygen therapy (LTOT) is linked to reduced exacerbations and hospitalizations among patients with chronic obstructive pulmonary disease (COPD), interstitial lung disease (ILD), and pulmonary ...

Adding mepolizumab to inhaled triple therapy significantly improved exacerbation outcomes compared with placebo in adults with chronic obstructive pulmonary disease (COPD), based on data from the ...

Alternative models of PR delivery should be evaluated in chronic respiratory diseases other than COPD. Since the BTS Guideline,1 several trials have informed on the potential utility of adjunctive ...

The American Society of Hematology (ASH) and the International Society on Thrombosis and Hemostasis (ISTH) released new and ...

Management and Outcome” in the journal Pulmonary & Respiratory Medicine states: “Normal physiologic changes that occur during pregnancy may produce fatal consequences in PAH patients. Current ...

has been approved since 2020 in the US as a maintenance treatment used to reduce exacerbations in people living with chronic obstructive pulmonary disease (COPD). Sales of Breztri were $677 ...

BENGALURU: The state health department has issued new guidelines for schools reopening after the summer vacation, in light of ...

Verona filed for approval of ensifentrine last year on the strength of clinical data showing significant improvements in lung function with the drug in COPD patients, as well as a reduction in ...